Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M300547200 on May 15, 2003

J. Biol. Chem., Vol. 278, Issue 30, 27362-27371, July 25, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
278/30/27362    most recent
M300547200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sablina, A. A.
Right arrow Articles by Kopnin, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sablina, A. A.
Right arrow Articles by Kopnin, B. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Tumor Suppressor p53 and Its Homologue p73{alpha} Affect Cell Migration*,

Anna A. Sablina {ddagger} §, Peter M. Chumakov {ddagger} ¶ || ** and Boris P. Kopnin § || {ddagger}{ddagger}

From the {ddagger}Lerner Research Institute, the Cleveland Clinic Foundation, Cleveland, Ohio 44195, §Institute of Carcinogenesis, Russian Cancer Research Center, Moscow, Russia 115478, and Engelhardt Institute of Molecular Biology, Moscow, Russia 119991

The p53 tumor suppressor plays a central role in the negative control of growth and survival of abnormal cells. Previously we demonstrated that in addition to these functions, p53 expression affects cell morphology and lamellar activity of the cell edge (Alexandrova, A., Ivanov, A., Chumakov, P. M., Kopnin, P. B., and Vasiliev, J. M. (2000) Oncogene 19, 5826–5830). In the present work we studied the effects of p53 and its homologue p73{alpha} on cell migration. We found that loss of p53 function correlated with decreased cell migration that was analyzed by in vitro wound closure test and Boyden chamber assay. The decreased motility of p53-deficient cells was observed in different cell contexts: human foreskin fibroblasts (BJ), human colon and lung carcinoma cell lines (HCT116 and H1299, respectively), as well as mouse normal fibroblasts from lung and spleen, peritoneal macrophages, and keratinocytes. On the other hand, overexpression of the p53 family member p73{alpha} stimulated cell migration. Changes in cell migration correlated directly with transcription activation induced by p53 or p73{alpha}. Noteworthy, p53 modulated cell motility in the absence of stress. The effect of p53 and p73{alpha} on cell migration was mediated through the activity of the phosphatidylinositol 3-kinase/Rac1 pathway. This p53/p73 function was mainly associated with some modulation of intracellular signaling rather than with stimulation of production of secreted motogenic factors. The identified novel activity of the p53 family members might be involved in regulation of embryogenesis, wound healing, or inflammatory response.


Received for publication, January 17, 2003 , and in revised form, May 13, 2003.

* This work was supported by startup funds from the Lerner Research Institute (to P. M. C.), the International Research Scholars Program of the Howard Hughes Medical Institute (to B. P. K.), and the Russian Foundation for Basic Research (to A. A. S., P. M. C., and B. P. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains Figs. 1-7.

|| Both senior authors contributed equally to this work.

** To whom correspondence may be addressed. Tel.: 216-444-9540; E-mail: chumakp{at}ccf.org.

{ddagger}{ddagger} To whom correspondence may be addressed. Tel.: 7-095-324-1739; E-mail: bkopnin{at}yahoo.com.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Sato, M. B. Vaughan, L. Girard, M. Peyton, W. Lee, D. S. Shames, R. D. Ramirez, N. Sunaga, A. F. Gazdar, J. W. Shay, et al.
Multiple Oncogenic Changes (K-RASV12, p53 Knockdown, Mutant EGFRs, p16 Bypass, Telomerase) Are Not Sufficient to Confer a Full Malignant Phenotype on Human Bronchial Epithelial Cells
Cancer Res., February 15, 2006; 66(4): 2116 - 2128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Fan, J. R. Harrell, S. Dipp, Z. Saifudeen, and S. S. El-Dahr
A novel pathological role of p53 in kidney development revealed by gene-environment interactions
Am J Physiol Renal Physiol, January 1, 2005; 288(1): F98 - F107.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement